share_log

HC Wainwright & Co. Reiterates Buy on Checkpoint Therapeutics, Maintains $34 Price Target

HC Wainwright & Co. Reiterates Buy on Checkpoint Therapeutics, Maintains $34 Price Target

HC Wainwright & Co.重申买入Checkpoint Therapeutics,维持34美元的目标股价
Moomoo 24/7 ·  03/22 14:11

HC Wainwright & Co. analyst Joseph Pantginis reiterates Checkpoint Therapeutics (NASDAQ:CKPT) with a Buy and maintains $34 price target.

HC Wainwright & Co. 分析师约瑟夫·潘吉尼斯重申Checkpoint Therapeutics(纳斯达克股票代码:CKPT)的买入并维持34美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发